NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 240 filers reported holding NEOGENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $377,000 | -98.4% | 31,038 | -95.5% | 0.00% | -98.1% |
Q4 2021 | $23,692,000 | -51.3% | 693,787 | -31.2% | 0.10% | -52.7% |
Q3 2021 | $48,634,000 | +19.6% | 1,008,175 | +12.0% | 0.22% | +25.7% |
Q2 2021 | $40,667,000 | -10.3% | 900,324 | -3.7% | 0.18% | -12.9% |
Q1 2021 | $45,348,000 | -46.5% | 934,450 | -40.6% | 0.20% | -57.9% |
Q4 2020 | $84,689,000 | +44.2% | 1,572,982 | -1.3% | 0.48% | +58.3% |
Q3 2020 | $58,735,000 | +3.8% | 1,593,031 | -17.9% | 0.30% | -6.2% |
Q2 2020 | $56,582,000 | -18.2% | 1,940,431 | -22.6% | 0.32% | -25.3% |
Q1 2020 | $69,212,000 | -4.9% | 2,506,782 | +0.8% | 0.43% | +23.1% |
Q4 2019 | $72,747,000 | +41.2% | 2,487,103 | -7.7% | 0.35% | +31.6% |
Q3 2019 | $51,527,000 | -13.0% | 2,694,940 | -0.2% | 0.27% | -12.2% |
Q2 2019 | $59,242,000 | +7.0% | 2,700,222 | -0.2% | 0.30% | +2.7% |
Q1 2019 | $55,355,000 | +93.0% | 2,705,536 | +19.0% | 0.30% | +63.0% |
Q4 2018 | $28,676,000 | -13.4% | 2,274,143 | +5.4% | 0.18% | +13.1% |
Q3 2018 | $33,116,000 | – | 2,157,426 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,516,313 | $14,011 | 8.43% |
Greenhouse Funds LLLP | 2,795,231 | $25,827,934 | 2.36% |
First Light Asset Management, LLC | 2,682,171 | $24,783,260 | 2.30% |
PERKINS CAPITAL MANAGEMENT INC | 197,700 | $1,827 | 1.93% |
Altium Capital Management LP | 285,000 | $2,633,400 | 1.34% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,654,543 | $15,287,977 | 0.95% |
EMERALD ADVISERS, LLC | 2,101,567 | $19,418,479 | 0.94% |
Bullseye Asset Management LLC | 105,997 | $980 | 0.53% |
OAK FAMILY ADVISORS, LLC | 101,194 | $935,033 | 0.50% |
FORMULA GROWTH LTD | 180,300 | $1,665,972 | 0.47% |